ANDA 76179, held by Actavis Labs Fl Inc. Tamoxifen Citrate.
As of Nov 15, 2026, ANDA 76179 (Tamoxifen Citrate), held by Actavis Labs Fl Inc, was first approved by FDA on Feb 20, 2003, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 20, 2003 | Original application | Approved | None posted |
| Tamoxifen CitrateEQ 10MG BASE · tablet;oral | Tamoxifen Citrate | Discontinued |
| Tamoxifen CitrateEQ 20MG BASE · tablet;oral | Tamoxifen Citrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
